Cargando…
Aminopeptidase B can bioconvert L-type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain
A prodrug approach is a powerful method to temporarily change the physicochemical and thus, pharmacokinetic properties of drugs. However, in site-selective targeted prodrug delivery, tissue or cell-specific bioconverting enzyme is needed to be utilized to release the active parent drug at a particul...
Autores principales: | Hugele, Agathe, Löffler, Susanne, Molina, Belén Hernández, Guillon, Melina, Montaser, Ahmed B., Auriola, Seppo, Huttunen, Kristiina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631218/ https://www.ncbi.nlm.nih.gov/pubmed/36339537 http://dx.doi.org/10.3389/fphar.2022.1034964 |
Ejemplares similares
-
l-Type Amino Acid Transporter 1 (LAT1/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons, Astrocytes and Microglia
por: Huttunen, Johanna, et al.
Publicado: (2019) -
Comparison of Experimental Strategies to Study l-Type Amino Acid Transporter 1 (LAT1) Utilization by Ligands
por: Huttunen, Johanna, et al.
Publicado: (2021) -
Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis
por: Markowicz-Piasecka, Magdalena, et al.
Publicado: (2020) -
L-Type Amino Acid Transporter 1-Utilizing Prodrugs of Ketoprofen Can Efficiently Reduce Brain Prostaglandin Levels
por: Montaser, Ahmed, et al.
Publicado: (2020) -
L-Type amino acid transporter 1 as a target for drug delivery
por: Puris, Elena, et al.
Publicado: (2020)